2m 2m 2m 2m 2m 2m 2m
Annovis Bio (ANVS)
NYSE
$1.75-$0.005 (-0.29%)
Price as of Aug 03, 2026 12:44 PM EDT- $74.4MMarket Cap
- -30.28%1-Year Change
- BiotechnologyIndustry
Annovis Bio (ANVS)
$1.75-$0.005 (-0.29%)
ANVS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.75 | ||
Change | -$0.02 (-1.13%) | ||
Open | $1.81 | ||
High | $1.81 | ||
Low | $1.70 | ||
Previous Close | $1.77 | ||
Volume | 353,013 | ||
30-Day Average Volume | 790,496 | ||
1-Week Change | 5.42% | ||
1-Month Change | -5.91% | ||
1-Year Change | -30.28% | ||
3-Year Change | -87.31% | ||
5-Year Change | -94.92% | ||
Fundamentals | |||
Shares Outstanding | 42.5M | ||
Total Assets | $16.2M | ||
Market Cap | $74.4M | ||
Enterprise Value | $60.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$17.6M | ||
Free Cash Flow | -$9.0M | ||
EBIT | -$17.6M | ||
EBITDA | -$17.6M | ||
Net Working Capital | $1.4M | ||
EPS | -$0.63 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 24 | ||
P/E | -3 | ||
PEG | 0 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue